staphylococcal enterotoxin B

01/01/2007 - "The implication of IFN-gamma in the pathophysiology of lethal shock induced in mice after a secondary challenge with the SAg staphylococcal enterotoxin B (SEB) prompted us to study the regulation of IFN-gamma secretion and the intracellular response. "
11/01/1997 - "In the present study peripheral T cell tolerance and the occurrence of shock were evaluated in young and old mice after injection of Staphylococcal enterotoxin B (SEB). "
09/01/1994 - "In the present study, we analyzed the in vivo production and the regulatory role of NO in the shock syndrome induced by staphylococcal enterotoxin B (SEB) in mice. "
09/01/2013 - "Staphylococcal enterotoxin B (SEB) causes lethal shock by potently stimulating the host immune response. "
03/18/2011 - "T-cell stimulating activity of Staphylococcal enterotoxin B (SEB) is an important factor in the pathogenesis of certain staphylococcal diseases including SEB mediated shock. "

06/01/2008 - "Staphylococcal enterotoxin B (SEB) has been the focus of a number of studies due to its ability to promote septic shock and a massive impact on the human immune system. "
01/01/2013 - "Determination of C5a in murine models of staphylococcal enterotoxin B-induced toxic shock."
07/20/2012 - "Staphylococcal enterotoxin B (SEB) is a potent toxin that can cause toxic shock syndrome and act as a lethal and incapacitating agent when used as a bioweapon. "
01/01/2012 - "Staphylococcal enterotoxin B toxic shock syndrome induced by community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA)."
11/01/2010 - "Murine models of staphylococcal enterotoxin B-induced toxic shock."

01/01/2021 - "Staphylococcal enterotoxin B (SEB) has been shown to aggravate airways eosinophilic inflammation. "
01/01/2020 - "However, little is known about the mechanisms underlying trafficking of bone marrow (BM) neutrophils during airway inflammation induced by Staphylococcal enterotoxin B (SEB). "
05/01/2011 - "However, no animal models have been reported to show nasal allergic inflammation by repeated inhalation with staphylococcal enterotoxin B (SEB) in the absence of adjuvant. "
05/01/2011 - "Repeated intranasal instillation with staphylococcal enterotoxin B induces nasal allergic inflammation in guinea pigs."
04/30/2004 - "Staphylococcal enterotoxin B and related toxins that target T cells have the capacity to elicit systemic inflammation, tissue injury, and death. "

10/03/2017 - "Herein, we evaluated the efficacy of human-mouse chimeric high-affinity neutralizing anti-staphylococcal enterotoxin B (SEB) antibodies in the treatment of experimental pneumonia caused by SEB-producing S. "
10/03/2017 - "Passive therapy with humanized anti-staphylococcal enterotoxin B antibodies attenuates systemic inflammatory response and protects from lethal pneumonia caused by staphylococcal enterotoxin B-producing Staphylococcus aureus."
11/01/2012 - "Inhalation of the superantigen,staphylococcal enterotoxin B (SEB), leads to the activation of the host T and invariant natural killer (iNK) T cells, thereby resulting in acute lung inflammation and respiratory failure but the underlying mechanism(s) of disease remain elusive, with limited treatment options. "
10/17/2013 - "In the current study we investigated the potential use of the hyaluronic acid synthase inhibitor 4-methylumbelliferone (4-MU) on staphylococcal enterotoxin B (SEB) induced acute lung inflammation. "
11/01/2011 - "Detection of tumor necrosis factor-α and interleukin-6 in exhaled breath condensate of rats with pneumonia due to staphylococcal enterotoxin B."

12/01/2017 - "Currently, Staphylococcal Enterotoxin B (SEB) has been introduced as an anti-tumor agent that is able to kill cancer cells. "
04/01/2017 - "Inhibition of squamous cancer growth in a mouse model by Staphylococcal enterotoxin B-triggered Th9 cell expansion."
05/01/2004 - "To prepare mutant Staphylococcal enterotoxin B(SEB) and observe its anti-tumor activity. "
05/01/2004 - "[Preparation and the anti-tumor activity of mutant Staphylococcal enterotoxin B]."
10/01/2002 - "Dendritic cell-tumor cell fusion and staphylococcal enterotoxin B treatment in a pancreatic tumor model."